Categories AlphaGraphs, Earnings, Health Care

Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results

Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also provided guidance for fiscal 2022.

Eli Lilly Q3 2022 earnings infographic

The Indianapolis-based pharmaceutical company said its revenues moved up 2% year-over-year to $6.94 billion in the third quarter as worldwide volumes increased by 13%.

The positive top-line performance translated into a 12% increase in net earnings, on an adjusted basis, to $1.98 per share. Unadjusted profit increased to $1.45 billion or $1.61 per share from $1.11 billion or $1.22 per share in the third quarter of 2021.


Check this space to read management/analysts’ comments on Eli Lilly’s Q3 2022 earnings


“With four more launches expected by the end of next year and a potential major new indication for tirzepatide, Lilly continues to make progress for patients with unaddressed medical needs through our significant commitment to invest in R&D, welcome the best talent, and turn breakthroughs in our labs into medicines for people around the world,” said David Ricks, CEO of Eli Lilly.

Prior Performance

  • Eli-Lilly-Q2-2022-Earnings-Infographic
  • Eli Lilly Q1 2022 earnings infographic

Most Popular

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731

Key takeaways from Visa’s Q3 2024 earnings report

Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in

Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024

Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top